Repare Therapeutics, Inc. (RPTX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1245413,
    "name": "Repare Therapeutics, Inc.",
    "stock_name": "Repare Therapeutics, Inc.",
    "full_name": "Repare Therapeutics, Inc.",
    "name_url": "stocks-analysis/repare-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "2.23",
    "chg": 0.1,
    "chgp": "4.94%",
    "dir": 1,
    "prev_price": "2.12",
    "mcapval": "73.46",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US7602731025",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "764.79 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/repare-therapeutics-inc-1245413-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Repare Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-repare-therapeutics-inc-technically-bullish-or-bearish-3547750",
        "imagepath": "",
        "date": "2025-09-20 20:02:18",
        "description": "As of 4 September 2025, the technical trend for Repare Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and daily moving averages also indicate a bullish stance. However, the monthly MACD is only mildly bullish, and Bollinger Bands show a mildly bearish signal on the monthly timeframe. The KST and Dow Theory are both bullish on the weekly and mildly bullish on the monthly. \n\nIn terms of performance, the stock has underperformed the S&P 500 over the past year and three years, with returns of -46.84% and -85.90%, respectively, compared to the S&P 500's 17.14% and 70.41%. However, it has outperformed the benchmark year-to-date with a return of 34.73% versus 12.22% for the S&P 500. Overall, the current technical stance is bullish, indicating a positive momentum in the short term...."
      },
      {
        "title": "Is Repare Therapeutics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-repare-therapeutics-inc-overvalued-or-undervalued-3544031",
        "imagepath": "",
        "date": "2025-09-20 18:35:42",
        "description": "As of 8 August 2025, the valuation grade for Repare Therapeutics, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. The company is overvalued based on its current financial metrics, particularly given its Price to Book Value of 0.50 and an EV to EBITDA ratio of 0.47, which suggest that the market is not pricing in the company's substantial losses and negative returns on equity of -98.52%. In comparison, PetIQ, Inc. shows a fair valuation with a P/E ratio of 27.10, highlighting the stark contrast in market perception between these two companies.\n\nRepare's recent stock performance has been troubling, with a one-year return of -46.84% compared to the S&P 500's 17.14%, and a staggering decline of -94.65% over the past five years, while the S&P 500 has gained 96.61% in the same period. This underperformance reinforces the notion that Repare Therapeuti..."
      }
    ],
    "total": 7,
    "sid": "1245413",
    "stock_news_url": "https://www.marketsmojo.com/news/repare-therapeutics-inc-1245413"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Repare Therapeutics, Inc. technically bullish or bearish?

2025-09-20 20:02:18

As of 4 September 2025, the technical trend for Repare Therapeutics, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and daily moving averages also indicate a bullish stance. However, the monthly MACD is only mildly bullish, and Bollinger Bands show a mildly bearish signal on the monthly timeframe. The KST and Dow Theory are both bullish on the weekly and mildly bullish on the monthly. In terms of performance, the stock has underperformed the S&P 500 over the past year and three years, with returns of -46.84% and -85.90%, respectively, compared to the S&P 500's 17.14% and 70.41%. However, it has outperformed the benchmark year-to-date with a return of 34.73% versus 12.22% for the S&P 500. Overall, the current technical stance is bullish, indicating a positive momentum in the short term....

Is Repare Therapeutics, Inc. overvalued or undervalued?

2025-09-20 18:35:42

As of 8 August 2025, the valuation grade for Repare Therapeutics, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its investment appeal. The company is overvalued based on its current financial metrics, particularly given its Price to Book Value of 0.50 and an EV to EBITDA ratio of 0.47, which suggest that the market is not pricing in the company's substantial losses and negative returns on equity of -98.52%. In comparison, PetIQ, Inc. shows a fair valuation with a P/E ratio of 27.10, highlighting the stark contrast in market perception between these two companies. Repare's recent stock performance has been troubling, with a one-year return of -46.84% compared to the S&P 500's 17.14%, and a staggering decline of -94.65% over the past five years, while the S&P 500 has gained 96.61% in the same period. This underperformance reinforces the notion that Repare Therapeuti...

View All News